Related Experiment Video
Updated: Jun 14, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Long-term mortality in patients diagnosed with meningococcal disease: a Danish nationwide cohort study
Casper Roed1, Lars Haukali Omland, Frederik Neess Engsig
1Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. casper.roed@rh.regionh.dk
Background:
In contrast to the case fatality rate of patients diagnosed with meningococcal disease (MD) the long-term mortality in these patients is poorly documented.
Methodology/Principal Findings:
We performed a nationwide, population-based cohort study including all Danish patients diagnosed with MD from 1977 through 2006 and alive one year after diagnosis. Data was retrieved from the Danish National Hospital Register, the Danish Civil Registration System and the Danish Register of Causes of Death. For each patient four age- and gender-matched individuals were identified from the population cohort. The siblings of the MD patients and of the individuals from the population cohort were identified. We constructed Kaplan-Meier survival curves and used Cox regression analysis, cumulative incidence function and subdistribution hazard regression to estimate mortality rate ratios (MRR) and analyze causes of death. We identified 4,909 MD patients, 19,636 individuals from the population cohort, 8,126 siblings of MD patients and 31,140 siblings of the individuals from the population cohort. The overall MRR for MD patients was 1.27 (95% confidence interval (CI), 1.12-1.45), adjusted MRR, 1.21 (95% CI, 1.06-1.37). MD was associated with increased risk of death due to nervous system diseases (MRR 3.57 (95% CI, 1.82-7.00). No increased mortality due to infections, neoplasms or cardiovascular diseases was observed. The MRR for siblings of MD patients compared with siblings of the individuals from the population cohort was 1.17 (95% CI, 0.92-1.48).
Conclusions:
Patients surviving the acute phase of MD have increased long-term mortality, but the excess risk of death is small and stems mainly from nervous system diseases.
Insights
Patients surviving meningococcal disease (MD) face a slightly increased long-term mortality risk, primarily due to nervous system diseases. This study quantifies the excess mortality risk for MD survivors.
Area of Science:
- Epidemiology
- Public Health
- Neurology
Background:
- Long-term mortality following meningococcal disease (MD) is not well-documented, unlike its case fatality rate.
- Understanding long-term outcomes is crucial for comprehensive patient care and public health strategies.
Purpose of the Study:
- To investigate the long-term mortality risk in patients who survived the acute phase of meningococcal disease.
- To identify specific causes of death associated with increased long-term mortality after MD.
Main Methods:
- A nationwide, population-based cohort study in Denmark (1977-2006) included 4,909 MD patients alive one year post-diagnosis.
- Matched population and sibling cohorts were used for comparison.
- Kaplan-Meier curves, Cox regression, and cumulative incidence functions analyzed mortality rate ratios (MRR).
Main Results:
- MD patients had an overall increased mortality rate ratio (MRR) of 1.21 (95% CI, 1.06-1.37).
- A significantly higher risk of death was observed for nervous system diseases (MRR 3.57).
- No increased mortality was found for infections, neoplasms, or cardiovascular diseases.
Conclusions:
- Individuals surviving meningococcal disease exhibit increased long-term mortality.
- The excess mortality risk is modest and predominantly linked to nervous system diseases.
- Sibling analysis did not reveal a significant familial risk increase.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Cryptococcal Meningitis
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Rocky Mountain Spotted Fever
